Search

This article explores the relationship between legislation on medically assisted reproduction (MAR) and public attitudes towards non-normative family structures in Europe. The study focuses on the access granted to single women and lesbian couples for MAR and how it aligns with attitudes towards single motherhood and same-sex parenthood. The findings suggest that MAR access for lesbian couples is more likely in contexts where same-sex parenthood is accepted, while access for single women seems disconnected from public opinion towards single motherhood. The paper highlights the potential for the combination of social acceptance and legal permissibility of MAR to facilitate the formation of new family forms. [Extracted from the article]

A new technology called METAPHOR, developed by the Institute for Bioengineering of Catalonia (IBEC), has the potential to reduce the time to pregnancy in assisted reproduction. METAPHOR generates 3D images of embryos obtained through in vitro fertilization, allowing for a non-invasive visualization of the embryo's metabolism. In studies with mice, the technology was able to double the success rate in selecting viable embryos compared to traditional microscopy. The method is also accurate in analyzing oocyte metabolism, allowing for the selection of the most suitable oocytes for in vitro fertilization. The researchers are currently working on fine-tuning the technology for human embryos and plan to bring it to assisted reproduction clinics in the future. [Extracted from the article]

A new report from China Agricultural University explores the evolving landscape of sperm selection techniques in Assisted Reproductive Technology (ART). The review critically assesses the efficacy of various methods, from traditional approaches to advanced techniques, in terms of sperm motility, morphology, DNA integrity, and other functional attributes. The researchers highlight the shift towards more sophisticated techniques that offer a comprehensive evaluation of sperm molecular properties, which could enhance prediction of fertilization success, improve embryo quality, and increase the chances of live birth. The integration of advanced sperm selection strategies in ART could lead to more cost-effective treatments with reduced duration and higher success rates. [Extracted from the article]

The following quote was obtained by the news editors from the background information supplied by the inventors: "Sperm washing is required to prepare sperm for use with in vitro fertilization (IVF) and intrauterine insemination (IUI). Washing semen removes dead sperm, immotile sperm, leukocytes, epithelial cells, and other cellular debris, which are thought to be harmful to viable sperm (1,2). The sperm wash device includes a first chamber section for holding an unwashed semen sample, a second chamber section for holding sperm wash media disposed over and attached to the first chamber section, and a ledge separating the first chamber section from the second chamber section. [Extracted from the article]

Keywords: Uppsala; Sweden; Europe; Assisted Reproduction; Female Genital Diseases and Conditions; Female Infertility; Health and Medicine; Legal Issues; Reproductive Medicine; Women's Health EN Uppsala Sweden Europe Assisted Reproduction Female Genital Diseases and Conditions Female Infertility Health and Medicine Legal Issues Reproductive Medicine Women's Health 360 360 1 06/05/23 20230606 NES 230606 2023 JUN 8 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Current study results on Reproductive Medicine - Female Infertility have been published. Keywords for this news article include: Uppsala, Sweden, Europe, Assisted Reproduction, Female Genital Diseases and Conditions, Female Infertility, Health and Medicine, Legal Issues, Reproductive Medicine, Women's Health, Uppsala University. [Extracted from the article]

Keywords: Berlin; Germany; Europe; CDC and FDA; Assisted Reproduction; Health and Medicine; Reproductive Medicine EN Berlin Germany Europe CDC and FDA Assisted Reproduction Health and Medicine Reproductive Medicine 942 942 1 06/05/23 20230606 NES 230606 2023 JUN 11 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Investigators publish new report on CDC and FDA. Berlin, Germany, Europe, CDC and FDA, Assisted Reproduction, Health and Medicine, Reproductive Medicine. [Extracted from the article]